Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 11

1.

Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.

Ettrup A, Palner M, Gillings N, Santini MA, Hansen M, Kornum BR, Rasmussen LK, NĂ¥gren K, Madsen J, Begtrup M, Knudsen GM.

J Nucl Med. 2010 Nov;51(11):1763-70. doi: 10.2967/jnumed.109.074021. Epub 2010 Oct 18.

2.

In vivo molecular and cellular imaging with quantum dots.

Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S.

Curr Opin Biotechnol. 2005 Feb;16(1):63-72. Review.

PMID:
15722017
3.

5-HT2 receptors.

Leysen JE.

Curr Drug Targets CNS Neurol Disord. 2004 Feb;3(1):11-26. Review.

PMID:
14965241
4.

5-HT1 receptors.

Lanfumey L, Hamon M.

Curr Drug Targets CNS Neurol Disord. 2004 Feb;3(1):1-10. Review.

PMID:
14965240
5.

Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.

Tan PZ, Baldwin RM, Van Dyck CH, Al-Tikriti M, Roth B, Khan N, Charney DS, Innis RB.

Nucl Med Biol. 1999 Aug;26(6):601-8.

PMID:
10587097
6.

The spectrum of behaviors influenced by serotonin.

Lucki I.

Biol Psychiatry. 1998 Aug 1;44(3):151-62. Review.

PMID:
9693387
7.

Modulation of central cholinergic activity by GABA and serotonin: PET studies with 11C-benztropine in primates.

Dewey SL, Smith GS, Logan J, Brodie JD.

Neuropsychopharmacology. 1993 Jun;8(4):371-6.

8.

Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.

Fletcher A, Cliffe IA, Dourish CT.

Trends Pharmacol Sci. 1993 Dec;14(12):41-8. Review.

PMID:
8122313
9.

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP.

Pharmacol Rev. 1994 Jun;46(2):157-203. Review.

PMID:
7938165
11.

Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats.

Lemaire C, Cantineau R, Guillaume M, Plenevaux A, Christiaens L.

J Nucl Med. 1991 Dec;32(12):2266-72.

Supplemental Content

Support Center